Contact Us
Phase-Xs | Biologics & Biosimilars | Coherent Market Insights

Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Anti-inflammatory drugs are the class of analgesics, which are used to treat multisystem inflammatory disorders. These drugs are used to relieve pain, reduce inflammation, or treat fever. These drugs are used worldwide on prescriptions as well as off label in tablets, capsules, creams, liquids, injections, sprays, and suppositories. Moreover, increasing incidence of acute and chronic diseases are expected to boost the market growth. For instance, according to an article published by the National Kidney Foundation Inc. in November 2019, reports that the prevalence of gout in the U.S. has been doubled since 1990s and now estimated that 3.9% i.e. 8.3 million adults in the U.S. had gout, amongst which 6.1 million were men and 2.2 million were women.

The global anti-inflammatory drugs market is estimated to be valued at US$ 79,830.2 million in 2020 and is expected to exhibit a CAGR of 8.6% during the forecast period (2020-2027).

Figure 1. Global Anti-inflammatory Drugs Market Share (%), by Region, 2020

Anti-inflammatory Drugs  | Coherent Market Insights

Ongoing research and development for the anti-inflammatory drugs is expected to propel growth of the global anti-inflammatory drugs market

Continuous research and development followed by approvals and launches of the anti-inflammatory drugs are expected to boost the market growth over the forecast period. For instance, in April 2020, InDex Pharmaceuticals Holding AB, received positive responses from the U.S. Food and Drug Administration (U.S. FDA) and European Medicines Agency (EMA) about the phase III trial of TLR9 agonist cobitolimod. This drug is a potential new medication for patients with active moderate to severe ulcerative colitis, a chronic inflammatory bowel disease.

However, failure of drug results in the clinical trial is expected to hinder the market growth over the forecast period. For instance, in July 2020, F. Hoffmann-La Roche AG, multinational healthcare company announced that its COVACTA trial of Actemra (tocilizumab), anti-inflammatory drug failed to meet its primary endpoint of improvement. The drug was supposed to support the patients who were hospitalized with severe COVID-19 pneumonia but failed as it proved ineffective and failed to improve outcomes in the disease.

request-sample

Anti-inflammatory Drugs Market Report Coverage

Report Coverage Details
Base Year: 2019 Market Size in 2020: US$ 79,830.2 Mn
Historical Data for: 2016 to 2019 Forecast Period: 2020 to 2027
Forecast Period 2020 to 2027 CAGR: 8.6% 2027 Value Projection: US$ 142,223.4 Mn
Geographies covered:
  • North America: U.S. and Canada
  • Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
  • Middle East: GCC Countries, Israel, and Rest of Middle East
  • Africa: South Africa, North Africa, and Central Africa
Segments covered:
  • By Drug Type: Nonsteroidal Anti-inflammatory Drugs (NSAIDs), Immune Selective Anti-inflammatory Derivatives (ImSAIDs), Anti-inflammatory Biologics, Corticosteroids.
  • By Application: Arthritis, Chronic Obstructive Pulmonary Disease (COPD), Multiple Sclerosis, Inflammatory Bowel Disease (IBD), Gout, Others.
  • By Route of Administration: Oral, Topical, Injection, Inhalation.
  • By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies.
Companies covered:

Pfizer, Inc., GlaxoSmithKline plc, Johnson & Johnson Services Inc., Merck & Company, Inc., Novartis AG, Amgen, Inc., AstraZeneca plc, Eli Lily and Company, AbbVie Inc., F. Hoffmann-La Roche AG, Bristol Myers Squibb Company, Biogen Inc., Sun Pharmaceutical Industries Ltd, Mylan, Inc., Aurobindo Pharma Limited, and Dr. Reddy’s Laboratories.

Growth Drivers:
  • Rising incidence of acute and chronic diseases
  • Product development and ongoing trials for anti-inflammatory drugs
Restraints & Challenges:
  • Side-effects of anti-inflammatory drugs
  • Drug failures

Figure 2. Global Anti-inflammatory Drugs Market Share (%), by Drug Type, 2020

Anti-inflammatory Drugs  | Coherent Market Insights

Increasing cases of acute and chronic diseases in North America is expected to boost the market growth

North America is expected to hold dominant position in the global anti-inflammatory drugs market, owing to increasing new cases of acute and chronic diseases in this region. For instance, according to an article published by the Arthritis Foundation in 2017, reports that the number of adults in the U.S. with doctor-diagnosed arthritis is estimated to increase by 49% to reach 78.4 million (25.9% of all adults) by 2040.

Global Anti-inflammatory Drugs Market – Impact of Coronavirus (COVID-19) Pandemic

The coronavirus (COVID-19) pandemic and lockdowns in various countries across the globe have impacted the financial status of businesses in all sectors. The private healthcare is one such sector which has been impacted significantly by the COVID-19 pandemic.

The lockdown in various countries due to the pandemic has placed an economic burden on the healthcare sector. Moreover, the coronavirus pandemic has hampered the development, production, and supply of drugs and other healthcare products and affected growth of healthcare businesses of various companies across the globe.

As a result, the impact of the COVID-19 pandemic is also expected to limit growth of the global anti-inflammatory drugs market during the forecast period.

Key Players

Major players operating in the global anti-inflammatory drugs market include Pfizer, Inc., GlaxoSmithKline plc, Johnson & Johnson Services Inc., Merck & Company, Inc., Novartis AG, Amgen, Inc., AstraZeneca plc, Eli Lily and Company, AbbVie Inc., F. Hoffmann-La Roche AG, Bristol Myers Squibb Company, Biogen Inc., Sun Pharmaceutical Industries Ltd, Mylan, Inc., Aurobindo Pharma Limited, and Dr. Reddy’s Laboratories among others.

Anti-inflammatory drugs are used in the treatment of acute and chronic diseases with inflammatory etiology. Therapeutic delivery of anti-inflammatory drugs to the target site of action and simultaneously avoiding undesired side effects. Anti-inflammatory drug supports to improve the quality of life and management of several rheumatic conditions such as arthritis. Anti-inflammatory drugs, especially the non-steroidal forms has significant role in medical practice, which has strong potential to boost the market growth in the near future.

Market Dynamics

Rising incidence of acute and chronic diseases such as arthritis is expected to drive anti-inflammatory drugs market growth. For instance, according to an article published by the Morbidity and Mortality Weekly Report, an epidemiological digest Centers for Disease Control and Prevention (CDC) in 2017, reports that arthritis affects over 1 in 4 adults  and in rural areas in the U.S., 1 in 3 adults has arthritis.

However, side effects of anti-inflammatory drugs are expected to hinder the market growth. For instance, according to an article published by the healthdirect, Australia in January 2020, reports that the anti-inflammatory medicines may also trigger asthma in some people. The same source also states that children under 16 years must not be prescribed aspirin due to the rare occurrence of Reye’s syndrome, which is potentially fatal.

Key features of the study:

  • This report provides in-depth analysis of the global anti-inflammatory drugs market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2020–2027), considering 2019 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new drug launches or approval, market trends,  regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global anti-inflammatory drugs market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Pfizer, Inc., GlaxoSmithKline plc, Johnson & Johnson Services Inc., Merck & Company, Inc., Novartis AG, Amgen, Inc., AstraZeneca plc, Eli Lily and Company, AbbVie Inc., F. Hoffmann-La Roche AG, Bristol Myers Squibb Company, Biogen Inc., Sun Pharmaceutical Industries Ltd, Mylan, Inc., Aurobindo Pharma Limited, and Dr. Reddy’s Laboratories among others
  • Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding future drug launches, drug class up-gradation, market expansion, and marketing tactics
  • The global anti-inflammatory drugs market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global anti-inflammatory drugs market.

Detailed Segmentation:

  • Global Anti-inflammatory Drugs Market, By Drug Type:
    • Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
    • Immune Selective Anti-inflammatory Derivatives (ImSAIDs)
    • Anti-inflammatory Biologics
    • Corticosteroids
  • Global Anti-inflammatory Drugs Market, By Application:
    • Arthritis
    • Chronic Obstructive Pulmonary Disease (COPD)
    • Multiple Sclerosis
    • Inflammatory Bowel Disease (IBD)
    • Gout
    • Others
  • Global Anti-inflammatory Drugs Market, By Route of Administration:
    • Oral
    • Topical
    • Injection
    • Inhalation
  • Global Anti-inflammatory Drugs Market, By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Global Anti-inflammatory Drugs Market, By Region:
    • North America
      • By Drug Type:
        • Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
        • Immune Selective Anti-inflammatory Derivatives (ImSAIDs)
        • Anti-inflammatory Biologics
        • Corticosteroids
      • By Application:
        • Arthritis
        • Chronic Obstructive Pulmonary Disease (COPD)
        • Multiple Sclerosis
        • Inflammatory Bowel Disease (IBD)
        • Gout
        • Others
      • By Route of Administration:
        • Oral
        • Topical
        • Injection
        • Inhalation
      • By Distribution Channel:
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • By Country:
        • U.S.
        • Canada
    • Latin America
      • By Drug Type:
        • Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
        • Immune Selective Anti-inflammatory Derivatives (ImSAIDs)
        • Anti-inflammatory Biologics
        • Corticosteroids
      • By Application:
        • Arthritis
        • Chronic Obstructive Pulmonary Disease (COPD)
        • Multiple Sclerosis
        • Inflammatory Bowel Disease (IBD)
        • Gout
        • Others
      • By Route of Administration:
        • Oral
        • Topical
        • Injection
        • Inhalation
      • By Distribution Channel:
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Drug Type:
        • Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
        • Immune Selective Anti-inflammatory Derivatives (ImSAIDs)
        • Anti-inflammatory Biologics
        • Corticosteroids
      • By Application:
        • Arthritis
        • Chronic Obstructive Pulmonary Disease (COPD)
        • Multiple Sclerosis
        • Inflammatory Bowel Disease (IBD)
        • Gout
        • Others
      • By Route of Administration:
        • Oral
        • Topical
        • Injection
        • Inhalation
      • By Distribution Channel:
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • By Country:
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Drug Type:
        • Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
        • Immune Selective Anti-inflammatory Derivatives (ImSAIDs)
        • Anti-inflammatory Biologics
        • Corticosteroids
      • By Application:
        • Arthritis
        • Chronic Obstructive Pulmonary Disease (COPD)
        • Multiple Sclerosis
        • Inflammatory Bowel Disease (IBD)
        • Gout
        • Others
      • By Route of Administration:
        • Oral
        • Topical
        • Injection
        • Inhalation
      • By Distribution Channel:
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • By Country:
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Drug Type:
        • Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
        • Immune Selective Anti-inflammatory Derivatives (ImSAIDs)
        • Anti-inflammatory Biologics
        • Corticosteroids
      • By Application:
        • Arthritis
        • Chronic Obstructive Pulmonary Disease (COPD)
        • Multiple Sclerosis
        • Inflammatory Bowel Disease (IBD)
        • Gout
        • Others
      • By Route of Administration:
        • Oral
        • Topical
        • Injection
        • Inhalation
      • By Distribution Channel:
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Drug Type:
        • Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
        • Immune Selective Anti-inflammatory Derivatives (ImSAIDs)
        • Anti-inflammatory Biologics
        • Corticosteroids
      • By Application:
        • Arthritis
        • Chronic Obstructive Pulmonary Disease (COPD)
        • Multiple Sclerosis
        • Inflammatory Bowel Disease (IBD)
        • Gout
        • Others
      • By Route of Administration:
        • Oral
        • Topical
        • Injection
        • Inhalation
      • By Distribution Channel:
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • By Country/Region:
        • South Africa
        • Central Africa
        • North Africa
  • Company Profiles
    • Pfizer, Inc.*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Highlights
      • Market Strategies
    • GlaxoSmithKline plc
    • Johnson & Johnson Services Inc.
    • Merck & Company, Inc.
    • Novartis AG
    • Amgen, Inc.
    • AstraZeneca plc
    • Eli Lily and Company
    • AbbVie Inc.
    • Hoffmann-La Roche AG
    • Bristol Myers Squibb Company
    • Biogen Inc.
    • Sun Pharmaceutical Industries Ltd
    • Mylan, Inc.
    • Aurobindo Pharma Limited
    • Reddy’s Laboratories

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Drug Type
      • Market Snippet, By Application
      • Market Snippet, By Route of Administration
      • Market Snippet, By Distribution Channel
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Pipeline Analysis
    • Reimbursement Scenario
    • Epidemiology
    • Pest Analysis
    • Regulatory Scenario
    • New Product Launches
    • Collaborations and Agreements
    • Market Trends
  4. Global Anti-inflammatory Drugs Market – Impact of Coronavirus (COVID-19) Pandemic
    • COVID-19 Market Scenario
    • Impact of COVID-19 Market on the Anti-inflammatory Drugs Products
  5. Global Anti-inflammatory Drugs Market, By Drug Type, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Immune Selective Anti-inflammatory Derivatives (ImSAIDs)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Anti-inflammatory Biologics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Corticosteroids
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  6. Global Anti-inflammatory Drugs Market, By Application, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Arthritis
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Chronic Obstructive Pulmonary Disease (COPD)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Multiple Sclerosis
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Inflammatory Bowel Disease (IBD)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Gout
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  7. Global Anti-inflammatory Drugs Market, By Route of Administration, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Oral
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Topical
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Injection
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Inhalation
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  8. Global Anti-inflammatory Drugs Market, By Distribution Channel, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Hospital Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Retail Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Online Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  9. Global Anti-inflammatory Drugs Market, By Region, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, By Region, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, For Regions, 2017–2027
    • North America
      • Market Size and Forecast, By Drug Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Route of Administration, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • U.S.
        • Canada
    • Latin America
      • Market Size and Forecast, By Drug Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Route of Administration, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Market Size and Forecast, By Drug Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Route of Administration, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Drug Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Route of Administration, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • Market Size and Forecast, By Drug Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Route of Administration, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Market Size and Forecast, By Drug Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Route of Administration, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country/Region, 2016 – 2027, (US$ Mn)
        • South Africa
        • Central Africa
        • North Africa
  10. Competitive Landscape
    • Heat Map Analysis
    • Market Share Analysis
      • Pfizer, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • GlaxoSmithKline plc
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Johnson & Johnson Services Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Merck & Company, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Novartis AG
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Amgen, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • AstraZeneca plc
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Eli Lily and Company
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • AbbVie Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Hoffmann-La Roche AG
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Bristol Myers Squibb Company
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Biogen Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Sun Pharmaceutical Industries Ltd
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Mylan, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Aurobindo Pharma Limited
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Reddy’s Laboratories
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
    • Analyst Views
  11. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 40 market data tables and 35 figures on "Anti-inflammatory Drugs Market” - Global forecast to 2027

FAQgrowicon

Frequently Asked Questions

The global anti-inflammatory drugs market is expected to exhibit a CAGR of 8.6% during the forecast period (2020-2027).
The global anti-inflammatory drugs market is estimated to be valued at US$ 79,830.2 million in 2020.
Rising incidence of chronic diseases, rising number of product approvals and launches, and ongoing research and development for anti-inflammatory drugs are favoring the market growth.
Nonsteroidal anti-inflammatory drugs (NSAIDs) segment is expected to be the leading drug type segment in the global anti-inflammatory drugs market during the forecast period (2020-2027).
North America anti-inflammatory drugs market is expected to generate highest revenue share during the forecast period.
Major players operating in the global anti-inflammatory drugs market include Pfizer, Inc., GlaxoSmithKline plc, Johnson & Johnson Services Inc., Merck & Company, Inc., Novartis AG, Amgen, Inc., AstraZeneca plc, Eli Lily and Company, AbbVie Inc., F. Hoffmann-La Roche AG, Bristol Myers Squibb Company, Biogen Inc., Sun Pharmaceutical Industries Ltd, Mylan, Inc., Aurobindo Pharma Limited, and Dr. Reddy’s Laboratories among others.
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner